Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS.
Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF
Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF

Catalyst Pharmaceuticals reports second-quarter net loss, plans to submit new drug for FDA approval

August 11, 2015 4:43 PM

Willie the Bee man